Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Marianna L Ianzano"'
Autor:
Patrizia Nanni, Giordano Nicoletti, Arianna Palladini, Stefania Croci, Annalisa Murgo, Marianna L Ianzano, Valentina Grosso, Valeria Stivani, Agnese Antognoli, Alessia Lamolinara, Lorena Landuzzi, Emmanuelle di Tomaso, Manuela Iezzi, Carla De Giovanni, Pier-Luigi Lollini
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39626 (2012)
In vivo studies of the metastatic process are severely hampered by the fact that most human tumor cell lines derived from highly metastatic tumors fail to consistently metastasize in immunodeficient mice like nude mice. We describe a model system bas
Externí odkaz:
https://doaj.org/article/84ef216e802b4cee8d005229b86ae354
Autor:
Carla De Giovanni, Patrizia Nanni, Lorena Landuzzi, Marianna L. Ianzano, Giordano Nicoletti, Stefania Croci, Arianna Palladini, Pier-Luigi Lollini
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background Insulin-like Growth Factor Receptor-1 (IGF1R) system sustains the genesis of rhabdomyosarcoma through IGF2 autocrine overexpression. While several IGF1R-targeted strategies have been investigated to interphere with rhabdomyosarcom
Externí odkaz:
https://doaj.org/article/98c06761c44e458a8f112936ff488f59
Autor:
Pier-Luigi Lollini, Santo Motta, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Stefania Croci, Agnese Antognoli, Marianna L. Ianzano, Valeria Stivani, Valentina Grosso, Annalisa Murgo, Francesco Pappalardo, Giordano Nicoletti, Arianna Palladini
Supplementary Figure Legend from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288481dbfaebe4c3b592b26f9acbab4e
https://doi.org/10.1158/0008-5472.22384161
https://doi.org/10.1158/0008-5472.22384161
Supplementary Methods from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Autor:
Pier-Luigi Lollini, Santo Motta, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Stefania Croci, Agnese Antognoli, Marianna L. Ianzano, Valeria Stivani, Valentina Grosso, Annalisa Murgo, Francesco Pappalardo, Giordano Nicoletti, Arianna Palladini
Supplementary Methods from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b76587cede6c3095087f241d68e259
https://doi.org/10.1158/0008-5472.22384158
https://doi.org/10.1158/0008-5472.22384158
Autor:
Pier-Luigi Lollini, Santo Motta, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Stefania Croci, Agnese Antognoli, Marianna L. Ianzano, Valeria Stivani, Valentina Grosso, Annalisa Murgo, Francesco Pappalardo, Giordano Nicoletti, Arianna Palladini
Cancer vaccine feasibility would benefit from reducing the number and duration of vaccinations without diminishing efficacy. However, the duration of in vivo studies and the huge number of possible variations in vaccination protocols have discouraged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0c8e75daf877f904f7988e3cd50ed1
https://doi.org/10.1158/0008-5472.c.6500790
https://doi.org/10.1158/0008-5472.c.6500790
Autor:
Pier-Luigi Lollini, Santo Motta, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Stefania Croci, Agnese Antognoli, Marianna L. Ianzano, Valeria Stivani, Valentina Grosso, Annalisa Murgo, Francesco Pappalardo, Giordano Nicoletti, Arianna Palladini
Supplementary Tables 1-4 from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c3899141241d55d9d80fa21ca96bfb
https://doi.org/10.1158/0008-5472.22384155
https://doi.org/10.1158/0008-5472.22384155
Autor:
Pier-Luigi Lollini, Santo Motta, Patrizia Nanni, Carla De Giovanni, Lorena Landuzzi, Stefania Croci, Agnese Antognoli, Marianna L. Ianzano, Valeria Stivani, Valentina Grosso, Annalisa Murgo, Francesco Pappalardo, Giordano Nicoletti, Arianna Palladini
Supplementary Figure 1 from In silico Modeling and In vivo Efficacy of Cancer-Preventive Vaccinations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b1c90744c0188995653d834fa5cf6a5
https://doi.org/10.1158/0008-5472.22384164.v1
https://doi.org/10.1158/0008-5472.22384164.v1
Autor:
Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Willem Adriaan de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni, Adam F. Sander
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effec
Externí odkaz:
https://doaj.org/article/e1b993a0c5c5445cb0c1372cb80b222f
Autor:
Tania Balboni, Claudio Ceccarelli, Maria Pia Foschini, Mario Taffurelli, Veronica Giusti, Maria C. Cucchi, Francesca Ruzzi, Roberta Laranga, Laura Scalambra, Pier Luigi Lollini, Carla De Giovanni, Arianna Palladini, Raffaele Calogero, Simone Zanotti, Marianna L. Ianzano, Enrico Di Oto, Patrizia Nanni, Maddalena Arigoni, Martina Olivero, Giordano Nicoletti, Lorena Landuzzi, Massimiliano Dall'Ora, Donatella Santini, Sofia Asioli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
We established patient-derived xenografts (PDX) from human primary breast cancers and studied whether stability or progressive events occurred during long-term in vivo passages (up to 4 years) in severely immunodeficient mice. While most PDX showed s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6afbede2c461e88153a2425f4994655d
https://doaj.org/article/59a0895a37d34757859e7e9b853a7ad6
https://doaj.org/article/59a0895a37d34757859e7e9b853a7ad6
Autor:
Pier Luigi Lollini, Giordano Nicoletti, Carla De Giovanni, Patrizia Nanni, Francesca Ruzzi, Lorena Landuzzi, Elena Nironi, Marianna L. Ianzano, Laura Scalambra, Raffaele Calogero, Maddalena Arigoni, M. Olivero, Roberta Laranga, Veronica Giusti, Arianna Palladini
Publikováno v:
Oncogenesis, Vol 10, Iss 11, Pp 1-12 (2021)
Oncogenesis
Oncogenesis
HER2-positive breast cancers may lose HER2 expression in recurrences and metastases. In this work, we studied cell lines derived from two transgenic mammary tumors driven by human HER2 that showed different dynamics of HER2 status. MamBo89HER2stable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e10666c8b5a04758676e3b30e3dad8c
https://doi.org/10.1038/s41389-021-00360-9
https://doi.org/10.1038/s41389-021-00360-9